Insilco Epitope Analysis of Conventional Influenza Vaccine (CIV), Indian Influenza Strain and 2011– 2012 INFLUENZA Vaccine Strain Recommended by WHO
Keywords:
H1N1, Influenza A, T-cell epitopes, pandemic, hemagglutinin/HA and neuraminidase/NAAbstract
Epitopes shared by the influenza vaccine and influenza viruses trigger the protective effect of vaccine immunization against influenza infection. Antigenic relationships among contemporary viruses and vaccine viruses are of prime importance in determining vaccine composition. Epitope predicted done by using T-cell epitopes prediction tools like NetCTL and CTL-Pred of the hemagglutinin (HA) and neuraminidase (NA) protein sequences contained in CIVstrain, Indian influenza strain and 2011- 2012 influenza vaccinestrain. Predicted epitopes are clustered with the help of Epitope Cluster Analysis module of IEDB analysis resource to remove duplication of peptide. Prediction of Binding affinity of peptides toward the TAP transporter was carried out by TAP Pred online service. Epitope analysis of different vaccinestrains (CIV and 2011- 2012 influenza vaccine) and Indian influenza strain by using (1)NetCTL server showed that there is conservation in epitope but it is maximum of 50% in HA of Indian influenzastrain and for NA there is no conservation in epitope with respect to CIV and 2011- 2012 influenza vaccinestrain. (2) CTL-Pred server showed that there is conservation in epitopes but it is maximum of 26.66% in HA of Indian influenzastrain and for NA there is 20% conservation in epitopes with respect to CIV and 2011- 2012 influenza vaccinestrain. This is perhaps the first report describing conservation of epitope in strain taken for analysis and found that there is very low level of conservation in surface protein HA & NA of Indian influenzastrain. Indian epitopes are more conserved in 2011-2012 influenza vaccinestrain compared to CIV thus there is chance of cross reactivity. As per our knowledge present study may facilitate the development of better therapeutics and preventive strategies, as well as impart clues for novel H1N1 diagnostic and vaccine development.
Downloads
Additional Files
Published
Issue
Section
License
COPYRIGHT NOTICE
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
_______________
We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |